COMPARATIVE ANALYSIS OF CONSUMER PROPERTIES OF VALSARTAN-CONTAINING DRUGS IN TERMS OF ASYMMETRIC INFORMATION
DOI:
https://doi.org/10.11603/2312-0967.2020.3.11426Keywords:
package inserts, arterial hypertension, combined valsartan-containing drug, asymmetric informationAbstract
The aim of the work. Comparative analysis of package inserts of combined valsartan-containing drugs in terms of asymmetric information.
Materials and Methods. Data of the State Register of Medicines of Ukraine as of September 1, 2019, in particular 7 package inserts of trademarks of Combined Valsartans. As research methods content, comparative, logical, contextual and qualitative analysis were applied.
Results and Discussion. There is a discrepancy in some sections of the text contents of 7 trademarks of Combined Valsartans. The results confirmed the asymmetry of information about the pharmacological identity of drugs-analogues without prooving of bioequivalence data. Also, it shows the need to take into consideration the communicative differences in the package inserts of analogues to ensure safe prescribing of drugs and reduce drug problems due to their use.
Conclusions. The analysis allows us to conclude that the information in the package inserts provided by the manufacturers is not complete. In order to ensure the reliable and safe administration of the studied drugs, healthcare professionals should not forget about the established differences in their consumer properties and individual approach to use by patients.
References
Hromovyk BP, Parnovskyi BL, Unhurian LM. [Realities of information asymmetry in pharmaceutical care]. Odeskyi medychnyi zhurnal. 2012;3: 30-3. Ukrainian.
On approval of the Procedure for examination of registration materials for medicinal products submitted for state registration (re-registration), as well as examination of materials on amendments to registration materials during the registration certificate: Order of the Ministry of Health of Ukraine dated August 26. 2005 No. 426. [Internet]. Available from: http://zakon2.rada.gov.ua/ laws/show/z1069–05
Hadiak IV, Hromovyk BP. [Study of the content of officially approved information on the medical use of trademarks tamsulosin]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2018;1: 20-7. Ukrainian.
Hromovyk BP, Matviichuk MIe. [Study of information asymmetry of regulatory documents on drugs for pharmacotherapy of depressive disorders in pregnant women and women in labor]. Farmatsevtychnyi chasopys. 2019;3: 111-22. Ukrainian. DOI.org/10.11603/2312-0967.2019.3.10408.
Prohibition of valsartan: The State Medical Service recommends that manufacturers analyze samples of finished products [Internet]. Morion; 2018. Available from: https://www.apteka.ua/article/467032.
State Register of Medicines of Ukraine [Internet]. Available from: http://www.drlz.com.ua
Handbook of drug equivalence [Internet]. Available from: https://rx.ua/ru/inn-mnn/valsartan-gidrohlorotiazid.
Unhurian LM, Kresiun VY, Hromovyk BP. [Contents of the instructions for medical use of analogue drugs in terms of asymmetry of information and drug-related problems]. Odeskyi medychnyi zhurnal. 2013;6: 27-32. Ukrainian.
On approval and introduction of medical and technological documents on standardization of medical care at arterial hypertension: the Order of the Ministry of Health of Ukraine of May 24, 2012 No. 384 [Internet]. Available from: http://www.apteka.ua/article/151151.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
